DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

 

Ultrasound Homepage

Could a Band-Aid-sized $100 ultrasound transducer be coming soon? Researchers are optimistic, as image quality matches or exceeds conventional systems

Philips to manage medical imaging equipment for Aussie providers for 20 years First-of-its-kind partnership in Australia and ASEAN Pacific region

Purdue research groups enhancing medical imaging with optical innovations Developing optical ultrasound and 3D printed, optical phantoms

Olympus enters separate collabs on endoscopic ultrasound and 3D surgery Partners with Hitachi Healthcare Americas and FlexDex

Philips unveils new ultrasounds for general and interventional cardiology Equipped with anatomical intelligence

China hits back with new tariffs affecting medical imaging equipment More than 5,000 items affected, including X-ray tubes and gamma-ray equipment

FDA greenlights focused ultrasound trial for Alzheimer's treatment Involves temporarily opening the blood-brain barrier

Could AI and 3D printing be the future of OB/GYN ultrasound? Few specialities are equally poised to embrace these cutting edge tools

Healcerion gets FDA nod for wireless ultrasound SONON 300L is 1/10th the cost of traditional systems

All-optical ultrasound could pave way for combined MR-ultrasound imaging Three orders of magnitude faster than current optical systems

Contrast enhanced ultrasound in pediatric patients

By Dr. Beth McCarville
From the March 2018 issue of DOTmed HealthCare Business News magazine

At St. Jude Children’s Research Hospital, we recently treated a 10-year-old girl with recurrent acute myelogenous leukemia who had undergone a bone marrow transplant.

Shortly after the transplant, she developed hepatic-veno-occlusive disease, a condition in which some of the small veins in the liver are obstructed.

Story Continues Below Advertisement

OR Tables, Treatment/GYN/Uro Chairs, Transport Stretchers, Hospital/ICU Bed

iMS combines the superior service of Oakworks Medical and advanced manufacturing technology of FAMED Medical Solutions. The goal of iMS, "Connecting Art and Medical Science" goes way beyond product with exceptional CareLink service. Contact us today!



She was treated with blood thinners, yet her liver function worsened. We performed color Doppler and 2-D spectral Doppler ultrasound of her liver to assess the blood flow. The examination revealed an absence of flow in the main portal vein, but it was unclear whether this was due to portal vein thrombosis (a blockage or narrowing of the portal vein by a blood clot) or venous stasis (a risk factor for forming blood clots in veins). Portal vein thrombosis would require delivery of tissue plasminogen activator (TPA) directly into the portal vein while venous stasis could be managed conservatively.

In this patient, intravascular TPA carried numerous associated risks and therefore, it was crucial to confirm the presence of thrombus. Because the patient had undergone myeloablation in preparation for bone marrow transplantation, she was thrombocytopenic, coagulopathic and at a high risk of bleeding from invasive procedures such as required for TPA administration.

Also, her transplant had induced renal insufficiency. Because of this, she was not a good candidate for any imaging procedure requiring the use of an iodinated intravenous contrast agent due to the potential for toxicity in the kidneys. Moreover, because she was in critical condition, she was not a good candidate for transport to the imaging department for MR angiography.


She was, however, an ideal candidate for contrast enhanced ultrasound (CEUS). Ultrasound contrast agents are not metabolized by the kidneys, so they can be safely administered to patients with renal insufficiency. Ultrasound is also a portable modality that can be easily transported outside of the radiology department.

We performed a CEUS exam at the patient’s bedside which clearly demonstrated reversal of flow in the main portal vein. In this case, CEUS answered a crucial clinical question while eliminating the need for a risky invasive procedure, avoided the potential nephrotoxicity from iodinated contrast administration, avoided exposing the patient to additional ionizing radiation and avoided transporting a critically ill patient out of the intensive care unit.

  Pages: 1 - 2 >>

Ultrasound Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
ALL RIGHTS RESERVED